{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:06:32Z","timestamp":1792857992668,"version":"4.5.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Among patients with structural heart disease with ventricular tachycardia (VT) refractory to medical therapy and catheter ablation, cardiac stereotactic body radiotherapy (SBRT) is a paradigm-changing treatment option. This study aims to assess the efficacy of cardiac SBRT in refractory VT by comparing the rates of VT episodes, anti-tachycardia pacing (ATP) therapies, and implantable cardioverter-defibrillator (ICD) shocks post-SBRT with pre-SBRT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We performed a comprehensive literature search and included all clinical studies reporting outcomes on cardiac SBRT for VT. Treatment efficacy was evaluated as random-effects pooled rate-ratios of VT episodes, ATP therapies and ICD shocks post-SBRT (after 6-week blanking) and pre-SBRT, with patients serving as their own controls. Post-SBRT overall survival was assessed using Kaplan\u2013Meier method. We included 23 studies published 2017\u201324 reporting on 225 patients who received cardiac SBRT, with median follow-up 5.8\u201328 months. There was significant heterogeneity among the studies for all three efficacy endpoints (P &amp;lt; 0.00001). The random-effects pooled rate-ratios of VT episodes, ATP therapies and ICD shocks post- vs. pre-SBRT were 0.10 (95% CI 0.06, 0.16), 0.09 (0.05, 0.15), and 0.09 (0.05, 0.17), respectively (all P &amp;lt; 0.00001). The most common reported complications included pericardial (8.0%, including 0.9% late oesophagogastro-pericardial fistula) and pulmonary (5.8%). There was no change in left ventricular ejection fraction post-SBRT (P = 0.3) but some studies reported an increase in mitral regurgitation. The combined 3-, 12-, and 24-month overall patient survival was 0.86 (0.80, 0.90), 0.72 (0.65, 0.78), and 0.57 (0.47, 0.67), respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among patients with refractory VT in context of structural heart disease, VT burden and ICD shocks are dramatically reduced following cardiac SBRT. The overall mortality in this population with heart failure and refractory VT receiving palliative cardiac SBRT remains high.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euae305","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T15:33:42Z","timestamp":1734968022000},"source":"Crossref","is-referenced-by-count":26,"title":["Stereotactic cardiac radiotherapy for refractory ventricular tachycardia in structural heart disease patients: a systematic review"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5317-6024","authenticated-orcid":false,"given":"Amulya","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Kansas Medical Center , 3901 Rainbow Blvd., Mail Stop 4023, Kansas City, KS 66160 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0133-0645","authenticated-orcid":false,"given":"Zeeshan","family":"Sattar","sequence":"additional","affiliation":[{"name":"Department of General and Hospital Medicine, The University of Kansas Medical Center , Kansas City, KS ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nourhan","family":"Chaaban","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The University of Kansas School of Medicine , Wichita, KS ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2167-6961","authenticated-orcid":false,"given":"Sagar","family":"Ranka","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Icahn School of Medicine at Mount Sinai , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Carlson","sequence":"additional","affiliation":[{"name":"University of Denver, Natural Sciences and Mathematics , Denver, CO ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9464-6934","authenticated-orcid":false,"given":"Farhad","family":"Sami","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Iowa , Iowa City, IA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-9904","authenticated-orcid":false,"given":"Clifford G","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Washington University in St. Louis , St. Louis, MO ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8127-2240","authenticated-orcid":false,"given":"Phillip S","family":"Cuculich","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Washington University in St. Louis , St. Louis, MO ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0543-2040","authenticated-orcid":false,"given":"Seth H","family":"Sheldon","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Kansas Medical Center , 3901 Rainbow Blvd., Mail Stop 4023, Kansas City, KS 66160 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Kansas Medical Center , 3901 Rainbow Blvd., Mail Stop 4023, Kansas City, KS 66160 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9733-6069","authenticated-orcid":false,"given":"David","family":"Akhavan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The University of Kansas Medical Center , Kansas City, KS ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9947-3849","authenticated-orcid":false,"given":"Amit","family":"Noheria","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Kansas Medical Center , 3901 Rainbow Blvd., Mail Stop 4023, Kansas City, KS 66160 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"key":"2025013112550137600_euae305-B1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"2025013112550137600_euae305-B2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic importance of defibrillator shocks in patients with heart failure","volume":"359","author":"Poole","year":"2008","journal-title":"N Engl J Med"},{"key":"2025013112550137600_euae305-B3","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"2025013112550137600_euae305-B4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"2025013112550137600_euae305-B5","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.hrthm.2015.05.036","article-title":"Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group study","volume":"12","author":"Tung","year":"2015","journal-title":"Heart Rhythm"},{"key":"2025013112550137600_euae305-B6","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1161\/CIRCULATIONAHA.108.788604","article-title":"Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial","volume":"118","author":"Stevenson","year":"2008","journal-title":"Circulation"},{"key":"2025013112550137600_euae305-B7","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jacc.2017.02.044","article-title":"Early mortality after catheter ablation of ventricular tachycardia in patients with structural heart disease","volume":"69","author":"Santangeli","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2025013112550137600_euae305-B8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N Engl J Med"},{"key":"2025013112550137600_euae305-B9","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.hrthm.2016.07.001","article-title":"Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease","volume":"13","author":"Kumar","year":"2016","journal-title":"Heart Rhythm"},{"key":"2025013112550137600_euae305-B10","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCEP.115.002765","article-title":"Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia","volume":"8","author":"Loo","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025013112550137600_euae305-B11","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMoa1613773","article-title":"Noninvasive cardiac radiation for ablation of ventricular tachycardia","volume":"377","author":"Cuculich","year":"2017","journal-title":"N Engl J Med"},{"key":"2025013112550137600_euae305-B12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCULATIONAHA.118.038261","article-title":"Phase I\/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia","volume":"139","author":"Robinson","year":"2019","journal-title":"Circulation"},{"key":"2025013112550137600_euae305-B13","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/europace\/euz133","article-title":"Stereotactic radiosurgery for ablation of ventricular tachycardia","volume":"21","author":"Neuwirth","year":"2019","journal-title":"Europace"},{"key":"2025013112550137600_euae305-B14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.hrthm.2019.09.028","article-title":"Clinical experience of stereotactic body radiation for refractory ventricular tachycardia in advanced heart failure patients","volume":"17","author":"Lloyd","year":"2020","journal-title":"Heart Rhythm"},{"key":"2025013112550137600_euae305-B15","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.hrthm.2020.02.036","article-title":"Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia","volume":"17","author":"Gianni","year":"2020","journal-title":"Heart Rhythm"},{"key":"2025013112550137600_euae305-B16","doi-asserted-by":"crossref","first-page":"10360","DOI":"10.1038\/s41598-021-89857-2","article-title":"First Asian population study of stereotactic body radiation therapy for ventricular arrhythmias","volume":"11","author":"Ho","year":"2021","journal-title":"Sci Rep"},{"key":"2025013112550137600_euae305-B17","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/pace.14254","article-title":"Case series on stereotactic body radiation therapy in non-ischemic cardiomyopathy patients with recurrent ventricular tachycardia","volume":"44","author":"Yugo","year":"2021","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025013112550137600_euae305-B18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10840-020-00849-0","article-title":"Non-invasive stereotactic body radiation therapy for refractory ventricular arrhythmias: an institutional experience","volume":"61","author":"Chin","year":"2021","journal-title":"J Interv Card Electrophysiol"},{"key":"2025013112550137600_euae305-B19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.hroo.2021.09.001","article-title":"Computational ECG mapping and respiratory gating to optimize stereotactic ablative radiotherapy workflow for refractory ventricular tachycardia","volume":"2","author":"Ho","year":"2021","journal-title":"Heart Rhythm O2"},{"key":"2025013112550137600_euae305-B20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10840-021-01060-5","article-title":"Stereotactic radioablation for the treatment of ventricular tachycardia: preliminary data and insights from the STRA-MI-VT phase Ib\/II study","volume":"62","author":"Carbucicchio","year":"2021","journal-title":"J Interv Card Electrophysiol"},{"key":"2025013112550137600_euae305-B21","doi-asserted-by":"crossref","first-page":"e001770","DOI":"10.1136\/openhrt-2021-001770","article-title":"Cardiac stereotactic ablative radiotherapy for control of refractory ventricular tachycardia: initial UK multicentre experience","volume":"8","author":"Lee","year":"2021","journal-title":"Open Heart"},{"key":"2025013112550137600_euae305-B22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jacep.2021.06.016","article-title":"Substrate modification using stereotactic radioablation to treat refractory ventricular tachycardia in patients with ischemic cardiomyopathy","volume":"8","author":"Qian","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"2025013112550137600_euae305-B23","doi-asserted-by":"crossref","first-page":"C248","DOI":"10.1093\/eurheartj\/suac016","article-title":"Stereotactic ablative radiotherapy in patients with refractory ventricular tachyarrhythmia","volume":"24","author":"Molon","year":"2022","journal-title":"Eur Heart J Suppl"},{"key":"2025013112550137600_euae305-B24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10840-022-01352-4","article-title":"Stereotactic body radioablation therapy as an immediate and early term antiarrhythmic palliative therapeutic choice in patients with refractory ventricular tachycardia","volume":"66","author":"Aras","year":"2023","journal-title":"J Interv Card Electrophysiol"},{"key":"2025013112550137600_euae305-B25","doi-asserted-by":"crossref","first-page":"e010955","DOI":"10.1161\/CIRCEP.122.010955","article-title":"Stereotactic radioablation for ventricular tachycardia in the setting of electrical storm","volume":"15","author":"Ninni","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025013112550137600_euae305-B26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.hroo.2022.11.006","article-title":"Short-term and long-term effects of noninvasive cardiac radioablation for ventricular tachycardia: a single-center case series","volume":"4","author":"Chang","year":"2023","journal-title":"Heart Rhythm O2"},{"key":"2025013112550137600_euae305-B27","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/europace\/euad020","article-title":"Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia: results of the prospective STARNL-1 trial","volume":"25","author":"van der Ree","year":"2023","journal-title":"Europace"},{"key":"2025013112550137600_euae305-B28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1253\/circrep.CR-23-0003","article-title":"Interim report of a Japanese phase II trial for cardiac stereotactic body radiotherapy in refractory ventricular tachycardia\u2014focus on target determination","volume":"5","author":"Amino","year":"2023","journal-title":"Circ Rep"},{"key":"2025013112550137600_euae305-B29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00066-023-02091-9","article-title":"Radiosurgery for ventricular tachycardia (RAVENTA): interim analysis of a multicenter multiplatform feasibility trial","volume":"199","author":"Krug","year":"2023","journal-title":"Strahlenther Onkol"},{"key":"2025013112550137600_euae305-B30","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad268","article-title":"Recurrences of ventricular tachycardia after stereotactic arrhythmia radioablation arise outside the treated volume: analysis of the Swiss cohort","volume":"25","author":"Herrera Siklody","year":"2023","journal-title":"Europace"},{"key":"2025013112550137600_euae305-B31","doi-asserted-by":"crossref","first-page":"109857","DOI":"10.1016\/j.radonc.2023.109857","article-title":"Stereotactic management of arrhythmia\u2014radiosurgery in treatment of ventricular tachycardia (SMART-VT). results of a prospective safety trial","volume":"188","author":"Miszczyk","year":"2023","journal-title":"Radiother Oncol"},{"key":"2025013112550137600_euae305-B32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.hrthm.2023.10.005","article-title":"One-year outcomes after stereotactic body radiotherapy for refractory ventricular tachycardia","volume":"21","author":"Arkles","year":"2024","journal-title":"Heart Rhythm"},{"key":"2025013112550137600_euae305-B33","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jacep.2023.12.002","article-title":"Efficacy and safety of stereotactic radiotherapy in patients with recurrent ventricular tachycardias: the Czech experience","volume":"10","author":"Ha\u0161kov\u00e1","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"2025013112550137600_euae305-B34","author":"Shi"},{"key":"2025013112550137600_euae305-B35","doi-asserted-by":"crossref","first-page":"849113","DOI":"10.3389\/fcvm.2022.849113","article-title":"Long term follow-up of stereotactic body radiation therapy for refractory ventricular tachycardia in advanced heart failure patients","volume":"9","author":"Wight","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025013112550137600_euae305-B36","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2025013112550137600_euae305-B37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jacep.2022.09.002","article-title":"Catheter ablation of ventricular tachycardia in patients with structural heart disease: a meta-analysis","volume":"9","author":"Virk","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"2025013112550137600_euae305-B38","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/europace\/euab326","article-title":"Oesophagopericardial fistula as a late complication of stereotactic radiotherapy for recurrent ventricular tachycardia","volume":"24","author":"Haskova","year":"2022","journal-title":"Europace"},{"key":"2025013112550137600_euae305-B39","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ijrobp.2019.08.032","article-title":"Longer term results from a phase I\/II study of EP-guided noninvasive cardiac radioablation for treatment of ventricular tachycardia (ENCORE-VT)","volume":"105","author":"Robinson","year":"2019","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"2025013112550137600_euae305-B40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3857\/roj.2021.00276","article-title":"Tailored stereotactic radiotherapy technique using deep inspiration breath-hold to reduce stomach dose for cardiac radioablation","volume":"39","author":"Cha","year":"2021","journal-title":"Radiat Oncol J"},{"key":"2025013112550137600_euae305-B41","doi-asserted-by":"crossref","first-page":"e021686","DOI":"10.1161\/JAHA.121.021686","article-title":"Radiation-Induced cardiovascular disease: review of an underrecognized pathology","volume":"10","author":"Belzile-Dugas","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2025013112550137600_euae305-B42","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.3390\/cancers14133273","article-title":"HIF-1\u03b1 inhibition improves anti-tumor immunity and promotes the efficacy of stereotactic ablative radiotherapy (SABR)","volume":"14","author":"Song","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025013112550137600_euae305-B43","doi-asserted-by":"crossref","first-page":"989886","DOI":"10.3389\/fcvm.2022.989886","article-title":"The effect of ionizing radiation through cardiac stereotactic body radiation therapy on myocardial tissue for refractory ventricular arrhythmias: a review","volume":"9","author":"Whitaker","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025013112550137600_euae305-B44","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/europace\/euu406","article-title":"Pulmonary vein isolation by radiosurgery: implications for non-invasive treatment of atrial fibrillation","volume":"17","author":"Bode","year":"2015","journal-title":"Europace"},{"key":"2025013112550137600_euae305-B45","doi-asserted-by":"crossref","first-page":"898222","DOI":"10.3389\/fcvm.2022.898222","article-title":"One-week dynamic changes in cardiac proteomes after cardiac radioablation in experimental rat model","volume":"9","author":"Kim","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025013112550137600_euae305-B46","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cardiores.2006.09.010","article-title":"Heavy ion radiation up-regulates Cx43 and ameliorates arrhythmogenic substrates in hearts after myocardial infarction","volume":"72","author":"Amino","year":"2006","journal-title":"Cardiovasc Res"},{"key":"2025013112550137600_euae305-B47","doi-asserted-by":"crossref","first-page":"107488","DOI":"10.1016\/j.carpath.2022.107488","article-title":"Inflammation and fibrosis characterize different stages of myocardial remodeling in patients after stereotactic body radiotherapy of ventricular myocardium for recurrent ventricular tachycardia","volume":"62","author":"Ku\u010dera","year":"2023","journal-title":"Cardiovasc Pathol"},{"key":"2025013112550137600_euae305-B48","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae214","article-title":"Patient selection, ventricular tachycardia substrate delineation and data transfer for stereotactic arrhythmia radioablation. A Clinical Consensus Statement of the European Heart Rhythm Association (EHRA) of the ESC and the Heart Rhythm Society (HRS)","author":"Zeppenfeld","year":"2024","journal-title":"Europace"},{"key":"2025013112550137600_euae305-B49","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/CIRCEP.114.001461","article-title":"Correlates and prognosis of early recurrence after catheter ablation for ventricular tachycardia due to structural heart disease","volume":"7","author":"Nagashima","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025013112550137600_euae305-B50","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.15420\/aer.2023.07","article-title":"Catheter ablation for ventricular tachycardia after MI: a reconstructed individual patient data meta-analysis of randomised controlled trials","volume":"12","author":"Reddy","year":"2023","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"2025013112550137600_euae305-B51","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.tcm.2023.12.008","article-title":"One-year mortality and causes of death after stereotactic radiation therapy for refractory ventricular arrhythmias: a systematic review and pooled analysis","volume":"34","author":"Benali","year":"2024","journal-title":"Trends Cardiovasc Med"},{"key":"2025013112550137600_euae305-B52","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/europace\/euac238","article-title":"STereotactic arrhythmia radioablation (STAR): the standardized treatment and outcome platform for stereotactic therapy of re-entrant tachycardia by a multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe","volume":"25","author":"Grehn","year":"2023","journal-title":"Europace"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euae305\/61270224\/euae305.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/27\/1\/euae305\/61270224\/euae305.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/27\/1\/euae305\/61270224\/euae305.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T07:55:50Z","timestamp":1738310150000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euae305\/7931915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,26]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euae305","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,12,24]]},"article-number":"euae305"}}